Literature DB >> 23743316

Overall and cause-specific mortality among patients with tuberculosis and multidrug-resistant tuberculosis.

K Blöndal1, K Rahu, A Altraja, P Viiklepp, M Rahu.   

Abstract

OBJECTIVE: To assess overall and cause-specific mortality among patients with tuberculosis (TB) and multidrug-resistant tuberculosis (MDR-TB) in Estonia.
DESIGN: A total of 2449 patients diagnosed with active respiratory TB from 1 January 2002 to 31 December 2009 were followed up retrospectively until 31 December 2011. To estimate the risk of death, standardised mortality ratios (SMR) and mortality rate ratios (RR) were calculated.
RESULTS: The SMR for all-cause mortality among those diagnosed with TB was 5.30 (95%CI 4.85-5.75) in males and 10.00 (95%CI 8.25-11.74) in females. The relative risk of death from TB was higher among MDR-TB patients (adjusted RR in males 2.98, 95%CI 2.00-4.44, and in females 3.26, 95%CI 1.42-7.50) than among non-MDR-TB patients. Among the cohort of successfully treated patients, the SMR for all-cause mortality was 3.46 (95%CI 3.08-3.84) in males and 6.24 (95%CI 4.86-7.88) in females. Lower education level and foreign ethnicity contributed to the higher risk of mortality. Previous history of successfully treated MDR-TB did not increase the risk of death compared to successfully treated non-MDR-TB.
CONCLUSIONS: Mortality among successfully treated TB and MDR-TB patients remained higher than among the general population. It was influenced by foreign ethnicity and lower education but, importantly, not by previous history of MDR-TB.

Entities:  

Mesh:

Year:  2013        PMID: 23743316     DOI: 10.5588/ijtld.12.0946

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  9 in total

1.  Post-tuberculosis mortality risk among immigrants to British Columbia, Canada, 1985-2015: a time-dependent Cox regression analysis of linked immigration, public health, and vital statistics data.

Authors:  C Andrew Basham; Mohammad Ehsanul Karim; Victoria J Cook; David M Patrick; James C Johnston
Journal:  Can J Public Health       Date:  2020-07-14

2.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

3.  High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.

Authors:  N Selvakumar; Vanaja Kumar; S Balaji; S Prabuseenivasan; R Radhakrishnan; Gomathi Sekar; V Chandrasekaran; T Kannan; Aleyamma Thomas; S Arunagiri; Puneet Dewan; Soumya Swaminathan
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

4.  Non-pulmonary cancer risk following tuberculosis: a nationwide retrospective cohort study in Lithuania.

Authors:  Ruta Everatt; Irena Kuzmickiene; Edita Davidaviciene; Saulius Cicenas
Journal:  Infect Agent Cancer       Date:  2017-05-31       Impact factor: 2.965

5.  Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries.

Authors:  Valérie Schwœbel; Arnaud Trébucq; Zacharie Kashongwe; Alimata S Bakayoko; Christopher Kuaban; Juergen Noeske; Souleymane H Harouna; Mahamadou B Souleymane; Alberto Piubello; François Ciza; Valentin Fikouma; Michel Gasana; Martial Ouedraogo; Martin Gninafon; Armand Van Deun; Elisa Tagliani; Daniela M Cirillo; Kobto G Koura; Hans L Rieder
Journal:  EClinicalMedicine       Date:  2020-02-10

6.  Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti.

Authors:  Yvetot Joseph; Zhiwen Yao; Akanksha Dua; Patrice Severe; Sean E Collins; Heejung Bang; Marc Antoine Jean-Juste; Oksana Ocheretina; Alexandra Apollon; Margaret L McNairy; Kathryn Dupnik; Etienne Cremieux; Anthony Byrne; Jean W Pape; Serena P Koenig
Journal:  J Int AIDS Soc       Date:  2021-07       Impact factor: 5.396

7.  Comparison of characteristics and mortality in multidrug resistant (MDR) and non-MDR tuberculosis patients in China.

Authors:  Yanni Sun; David Harley; Hassan Vally; Adrian Sleigh
Journal:  BMC Public Health       Date:  2015-10-06       Impact factor: 3.295

8.  Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.

Authors:  Martie van der Walt; Joey Lancaster; Karen Shean
Journal:  PLoS One       Date:  2016-03-07       Impact factor: 3.240

9.  Association of Mortality and Years of Potential Life Lost With Active Tuberculosis in the United States.

Authors:  Christian Lee-Rodriguez; Paul Y Wada; Yun-Yi Hung; Jacek Skarbinski
Journal:  JAMA Netw Open       Date:  2020-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.